AGREEMENT FOR PURCHASE AND SALE OF SHARES OF PREFERRED STOCK OF PEPGEN CORPORATIONAgreement for Purchase and Sale • August 14th, 2001 • Calypte Biomedical Corp • Laboratory analytical instruments • California
This Agreement is entered into effective as of April 17, 2001, (the “Effective Date”), by and between Biotechnology Development Fund I, L.P., a limited partnership organized under the laws of Delaware (“BDF I”), Biotechnology Development Fund II, L.P., a limited partnership organized under the laws of Delaware (“BDF II”), (together the “Purchasers”), and Calypte Biomedical Corporation (“Seller”), a Delaware corporation. The principal offices for the Purchasers and the Seller are shown below each party’s signature at the end of this Agreement. Pepgen Corporation (“Pepgen”), a California corporation with its principal offices at 1255 Harbor Parkway, Alameda, CA 94502, has executed and delivered this Agreement solely to acknowledge and consent to the sale of shares of Pepgen effected hereby.
